NeuroPace Q3 EPS $(0.28) Beats $(0.41) Estimate, Sales $16.43M Beat $14.22M Estimate
Portfolio Pulse from mahesh@benzinga.com
NeuroPace (NASDAQ:NPCE) reported Q3 earnings per share (EPS) of $(0.28), beating the analyst consensus estimate of $(0.41) by 31.71%. This is a 41.67% increase over losses from the same period last year. The company also reported quarterly sales of $16.43 million, beating the analyst consensus estimate of $14.22 million by 15.52%. This is a 47.23% increase over sales from the same period last year.
November 06, 2023 | 9:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NeuroPace's Q3 earnings and sales beat analyst estimates, showing significant improvement over the same period last year.
NeuroPace's Q3 earnings and sales exceeded analyst estimates, which is generally seen as a positive sign by investors. The significant year-over-year improvement in both earnings and sales suggests that the company's financial performance is improving, which could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100